Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

ILC1 cells contribute to hair loss in alopecia areata.

CBD can either promote or inhibit hair growth depending on the concentration used.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.